SARS-CoV-2 Reinfection and Severity of the Disease: A Systematic Review and Meta-Analysis
- PMID: 37112949
- PMCID: PMC10145185
- DOI: 10.3390/v15040967
SARS-CoV-2 Reinfection and Severity of the Disease: A Systematic Review and Meta-Analysis
Abstract
Since the discovery of SARS-CoV-2, changes in genotype and reinfection with different variants have been observed in COVID-19-recovered patients, raising questions around the clinical pattern and severity of primary infection and reinfection. In this systematic review, we summarize the results of 23 studies addressing SARS-CoV-2 reinfections. A total of 23,231 reinfected patients were included, with pooled estimated reinfection rates ranging from 0.1 to 6.8%. Reinfections were more prevalent during the Omicron variant period. The mean age of reinfected patients was 38.0 ± 6. years and females were predominant among reinfected patients (M/F = 0.8). The most common symptoms during the first and second infection were fever (41.1%), cough (35.7% and 44.6%), myalgia (34.5% and 33.3%), fatigue (23.8% and 25.6%), and headaches (24.4% and 21.4%). No significant differences of clinical pattern were observed between primary infection and reinfection. No significant differences in the severity of infection were observed between primary infection and reinfection. Being female, being a patient with comorbidities, lacking anti-nucleocapsid IgG after the first infection, being infected during the Delta and Omicron wave, and being unvaccinated were associated with a higher risk of reinfection. Conflicting age-related findings were found in two studies. Reinfection with SARS-CoV-2 suggests that natural immunity is not long-lasting in COVID-19 patients.
Keywords: COVID-19; SARS-CoV-2; coronavirus; reinfection; second infection; variant.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Word Health Organization (WHO) Coronavirus Disease (COVID-19) Pandemic. [(accessed on 25 June 2022)]. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
-
- To K.K., Hung I.F., Ip J.D., Chu A.W., Chan W.-M., Tam A.R., Fong C.H.-Y., Yuan S., Tsoi H.-W., Ng A.C.-K., et al. Coronavirus Disease 2019 (COVID-19) Reinfection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing. Clin. Infect. Dis. 2021;73:e2946–e2951. doi: 10.1093/cid/ciaa1275. - DOI - PMC - PubMed
-
- Ghorbani S.S., Taherpour N., Bayat S., Ghajari H., Mohseni P., Nazari S.S.H. Epidemiologic characteristics of cases with reinfection, recurrence, and hospital readmission due to COVID-19: A systematic review and meta-analysis. J. Med. Virol. 2022;94:44–53. doi: 10.1002/jmv.27281. - DOI - PMC - PubMed
-
- Center for Disease Control and Prevention Coronavirus Disease 2019 (COVID-19) 2021 Case Definition. [(accessed on 4 April 2023)]; Available online: https://ndc.services.cdc.gov/case-definitions/coronavirus-disease-2019-2...
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
